David V Goeddel - Net Worth and Insider Trading
David V Goeddel Net Worth
The estimated net worth of David V Goeddel is at least $159 Million dollars as of 2024-05-21. David V Goeddel is the Director, 10% Owner of Tenaya Therapeutics Inc and owns about 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $98 Million. David V Goeddel is the Director, 10% Owner of NGM Biopharmaceuticals Inc and owns about 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $34 Million. David V Goeddel is also the Director, 10% Owner of RAPT Therapeutics Inc and owns about 6,777,151 shares of RAPT Therapeutics Inc (RAPT) stock worth over $27 Million. Details can be seen in David V Goeddel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David V Goeddel has not made any transactions after 2024-02-12 and currently still holds the listed stock(s).
Transaction Summary of David V Goeddel
David V Goeddel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David V Goeddel owns 11 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .
Click here to see the complete history of David V Goeddel’s form 4 insider trades.
Insider Ownership Summary of David V Goeddel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RAPT | RAPT Therapeutics Inc | 2021-08-18 | 10 percent owner |
NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | director & 10 percent owner |
NRIX | Nurix Therapeutics Inc | 2021-05-07 | 10 percent owner |
2020-11-16 | 10 percent owner | ||
2021-11-12 | 10 percent owner | ||
2020-03-19 | 10 percent owner & other: Managing Partner | ||
2019-04-02 | 10 percent owner & other: Managing Partner | ||
2018-09-27 | other: Managing Partner | ||
2018-03-14 | 10 percent owner | ||
2021-08-25 | 10 percent owner | ||
2024-02-12 | director & 10 percent owner |
David V Goeddel Latest Holdings Summary
David V Goeddel currently owns a total of 3 stocks. Among these stocks, David V Goeddel owns 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) as of February 12, 2024, with a value of $98 Million and a weighting of 61.57%. David V Goeddel owns 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) as of November 16, 2023, with a value of $34 Million and a weighting of 21.35%. David V Goeddel also owns 6,777,151 shares of RAPT Therapeutics Inc (RAPT) as of November 4, 2019, with a value of $27 Million and a weighting of 17.08%.
Latest Holdings of David V Goeddel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TNYA | Tenaya Therapeutics Inc | 2024-02-12 | 22,999,565 | 4.25 | 97,748,151 |
NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | 22,008,593 | 1.54 | 33,893,233 |
RAPT | RAPT Therapeutics Inc | 2019-11-04 | 6,777,151 | 4.00 | 27,108,604 |
Holding Weightings of David V Goeddel
David V Goeddel Form 4 Trading Tracker
According to the SEC Form 4 filings, David V Goeddel has made a total of 6 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,222,222 shares on February 12, 2024, which cost David V Goeddel around $10 Million.
According to the SEC Form 4 filings, David V Goeddel has made a total of 50 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 50 buys and 0 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 26,811 shares on November 16, 2023, which cost David V Goeddel around $18,232.
According to the SEC Form 4 filings, David V Goeddel has made a total of 1 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RAPT Therapeutics Inc is the acquisition of 625,000 shares on November 4, 2019, which cost David V Goeddel around $8 Million.
Insider Trading History of David V Goeddel
- 1
David V Goeddel Trading Performance
GuruFocus tracks the stock performance after each of David V Goeddel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David V Goeddel is 26.3%. GuruFocus also compares David V Goeddel's trading performance to market benchmark return within the same time period. The performance of stocks bought by David V Goeddel within 3 months outperforms 39 times out of 61 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David V Goeddel's insider trading performs compared to the benchmark.
Performance of David V Goeddel
David V Goeddel Ownership Network
Ownership Network List of David V Goeddel
Ownership Network Relation of David V Goeddel
David V Goeddel Owned Company Details
What does RAPT Therapeutics Inc do?
Who are the key executives at RAPT Therapeutics Inc?
David V Goeddel is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .
RAPT Therapeutics Inc (RAPT) Insider Trades Summary
Over the past 18 months, David V Goeddel made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 39,000 shares made by William Ho , a net sale of 1,640 shares made by Dirk G. Brockstedt , and a net purchase of 5,000 shares made by Wendye Robbins .
In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,640 shares of RAPT Therapeutics Inc (RAPT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 35,640 shares.
RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
RAPT Therapeutics Inc Insider Transactions
David V Goeddel Mailing Address
Above is the net worth, insider trading, and ownership report for David V Goeddel. You might contact David V Goeddel via mailing address: C/o Column Group Lp, 1700 Owens Street, Suite 500, San Francisco Ca 94158.